Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TEMPO (iMOvifa) Glaucoma Screening

NCT06186388 is registered in ClinicalTrials.gov with Cape Fear Eye Institute as lead sponsor.

NCT NCT06186388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06186388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TEMPO (iMOvifa) Glaucoma Screening
Lead sponsor
Cape Fear Eye Institute
Phase
Not applicable
Overall status
Completed
Start date
December 5, 2023
Completion date
May 15, 2024
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma